Prelude Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-15,228
| Closed | -$619K | – | 1174 |
|
2023
Q2 | $619K | Buy |
15,228
+6,939
| +84% | +$282K | 0.04% | 338 |
|
2023
Q1 | $402K | Buy |
+8,289
| New | +$402K | 0.02% | 468 |
|
2022
Q4 | – | Sell |
-4,609
| Closed | -$231K | – | 1421 |
|
2022
Q3 | $231K | Buy |
+4,609
| New | +$231K | 0.01% | 989 |
|
2020
Q4 | – | Sell |
-1,300
| Closed | -$61K | – | 1378 |
|
2020
Q3 | $61K | Sell |
1,300
-7,531
| -85% | -$353K | ﹤0.01% | 816 |
|
2020
Q2 | $448K | Buy |
8,831
+4,856
| +122% | +$246K | 0.02% | 301 |
|
2020
Q1 | $177K | Sell |
3,975
-26,192
| -87% | -$1.17M | 0.01% | 268 |
|
2019
Q4 | $1.45M | Buy |
30,167
+29,757
| +7,258% | +$1.43M | 0.06% | 118 |
|
2019
Q3 | $14K | Sell |
410
-44,163
| -99% | -$1.51M | ﹤0.01% | 980 |
|
2019
Q2 | $2.01M | Buy |
44,573
+23,968
| +116% | +$1.08M | 0.1% | 96 |
|
2019
Q1 | $776K | Buy |
+20,605
| New | +$776K | 0.04% | 203 |
|
2018
Q4 | – | Sell |
-78,071
| Closed | -$3.67M | – | 1677 |
|
2018
Q3 | $3.67M | Sell |
78,071
-25,888
| -25% | -$1.22M | 0.21% | 56 |
|
2018
Q2 | $3.51M | Sell |
103,959
-65,004
| -38% | -$2.19M | 0.22% | 54 |
|
2018
Q1 | $4.57M | Sell |
168,963
-119,506
| -41% | -$3.23M | 0.33% | 44 |
|
2017
Q4 | $4.81M | Buy |
288,469
+107,090
| +59% | +$1.79M | 0.39% | 41 |
|
2017
Q3 | $3.63M | Sell |
181,379
-100,845
| -36% | -$2.02M | 0.33% | 56 |
|
2017
Q2 | $5.17M | Sell |
282,224
-13,971
| -5% | -$256K | 0.49% | 41 |
|
2017
Q1 | $2.92M | Buy |
296,195
+115,171
| +64% | +$1.13M | 0.28% | 67 |
|
2016
Q4 | $1.98M | Sell |
181,024
-34,947
| -16% | -$381K | 0.24% | 110 |
|
2016
Q3 | $3.03M | Buy |
215,971
+207,171
| +2,354% | +$2.9M | 0.32% | 50 |
|
2016
Q2 | $62K | Buy |
+8,800
| New | +$62K | 0.01% | 879 |
|
2015
Q4 | – | Sell |
-5,737
| Closed | -$153K | – | 1557 |
|
2015
Q3 | $153K | Buy |
5,737
+5,037
| +720% | +$134K | 0.02% | 640 |
|
2015
Q2 | $34K | Buy |
+700
| New | +$34K | ﹤0.01% | 1163 |
|